findmyKOL
Clinical trialNCT00243685CompletedPhase 2/PHASE3Interventional

Chemotherapy Drug Sensitivity Microculture (MiCK) Assay for Apoptosis

SponsorPierian BiosciencesEnrollment150Breast NeoplasmsLung NeoplasmsOvarian NeoplasmsSarcoma, Soft Tissue
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

DiaTech is a private company performing patient specific cancer chemosensitivity testing for patients and physicians. DiaTech Oncology is doing this clinical study to see if an experimental new technology called the microculture kinetic (MiCK) assay will predict treatment outcome and can help to direct the chemotherapy of cancer subjects. This study is focused on subjects diagnosed with breast, ovarian, lung, and colon malignancies and low-grade lymphomas. Study Objectives: * To evaluate the ability of the MiCK assay to predict the outcome of chemotherapy of cancer patients. * To evaluate the ability of the MiCK assay to guide chemotherapy of cancer patients.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Nashville Breast Center

    Nashville, Tennessee, United States

  • Nashville Oncology Associates

    Nashville, Tennessee, United States

  • Cancer Care Centers of South Texas

    San Antonio, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Sept 2006
Primary completion
—
Completion
31 May 2009
Last update posted
26 Jan 2012
Registered enrollment
150
Registry id
NCT00243685
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.